logo
Is Everest Group Stock Underperforming the Dow?

Is Everest Group Stock Underperforming the Dow?

Yahoo20 hours ago

With a market cap of $14.2 billion, Everest Group, Ltd. (EG) is a global provider of reinsurance and insurance solutions through its Insurance and Reinsurance segments. The company offers a broad range of property and casualty products, including treaty and facultative reinsurance, as well as specialty lines such as catastrophe, marine, aviation, and mortgage reinsurance.
Companies worth more than $10 billion are generally labeled as 'large-cap' stocks and Everest Group fits this criterion perfectly. The company operates across the United States, Europe, and internationally, serving clients through brokers and direct channels.
3 ETFs with Dividend Yields of 12% or Higher for Your Income Portfolio
Warren Buffett Famously Warned to 'Make Money While You Sleep' or 'You Will Work Until You Die': 5 Stocks To Invest Like Buffett
Unusually Active Put Options Signal Long Straddle Opportunity After Zoetis Downgrade
Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now!
Shares of the Hamilton, Bermuda-based company have declined 18.3% from its 52-week high of $407.30. Over the past three months, its shares have decreased 7.4%, underperforming the broader Dow Jones Industrials Average's ($DOWI) 1.4% rise during the same period.
Longer term, EG stock is down 8.2% on a YTD basis, a steeper drop than DOWI's marginal decline. Moreover, shares of Everest Group have dipped 11.8% over the past 52 weeks, compared to DOWI's 8.6% increase over the same time frame.
Despite a few fluctuations, the stock has been trading below its 50-day and 200-day moving averages since late October last year.
Shares of Everest Group tumbled nearly 6% following its Q1 2025 results on Apr. 30 due to a steep 71% drop in net income to $210 million ($4.90 per share). The company posted a significant pre-tax catastrophe loss of $472 million, primarily due to California wildfires, which contributed to a deteriorated combined ratio of 102.7%. Both adjusted EPS of $6.45 and revenue of $4.3 billion missed Wall Street expectations.
EG stock has performed weaker than its rival, SiriusPoint Ltd. (SPNT). SPNT stock has returned 17.9% YTD and 53.6% over the past 52 weeks.
Despite the stock's underperformance, analysts remain moderately optimistic about its prospects. The stock has a consensus rating of 'Moderate Buy' from 13 analysts in coverage, and as of writing, EG is trading below the mean price target of $391.75.
On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June
2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June

Yahoo

time11 minutes ago

  • Yahoo

2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June

The average healthcare stock has a yield of just 1.7%. Medtronic's dividend yield is 3.3%. Alexandria Real Estate Equities' yield is 7.4%. 10 stocks we like better than Medtronic › The healthcare sector isn't exactly known for offering huge yields, with Health Care Select Sector SPDR (NYSEMKT: XLV) offering a yield of just 1.7%. If dividend investors take some time to dig into the sector, however, they can do much better. For example, Medtronic (NYSE: MDT) has a 3.3% yield today, and Alexandria Real Estate Equities (NYSE: ARE) is offering a yield of 7.4%. Here's what you need to know about each of these high-yield healthcare stocks. Medtronic makes medical devices. It is one of the largest competitors in the space, making products across the cardiovascular, neuroscience, medical surgical, and diabetes categories. It has a leading position in each of the areas in which it operates, and it operates on a global scale. That said, the last few years haven't been the best ones for the company. Innovation, which is highly important in the healthcare space, can be lumpy. And given Medtronic's size, the business has become a little cumbersome. Growth has stalled out, and profitability has come under pressure. Investors have focused on the negatives pushing the shares lower and the dividend yield up toward the high end of Medtronic's historical yield range. If you are a dividend investor that thinks in decades and not days, however, this is likely to be an investment opportunity. The company's innovation pipeline is starting to turn into new-product introductions. As new products gain traction, financial performance is likely to improve. And management has been working to streamline the business with cost cuts and a move to refocus on its most profitable operations. To that end, the company is set to spin off its lower-margin diabetes division in 2026. The move is expected to be immediately accretive to earnings, and the dividend policy isn't expected to change. All in, Medtronic is doing what it needs to do to get back on the growth path. And that should support continued dividend increases; the medical device maker only has two years to go before it hits Dividend King status (50+ years of annual dividend increases). June could be an opportune time to buy the stock hand over fist. Alexandria is a real estate investment trust (REIT), which seems pretty far away from healthcare. Its primary focus is on office properties, which also seems a bit removed from healthcare. The key here is that the REIT owns biomedical research facilities, which combine research space and office space in one property. Both are important to each other since the research takes place in specialized space, while the analysis of that research takes place in a normal office environment. Alexandria is one of the largest pure play medical research REITs you can buy. Alexandria counts some of the largest and most important medical research groups as tenants, from both the private side of the equation and the government side. However, like any landlord, the REIT's revenues will be impacted by the occupancy levels of its properties. And those rise and fall over time. Right now, occupancy is relatively weak, dropping to 91.7% at the end of the first quarter of 2025 from 94.6% at the end of 2024. Swings like this happen from time to time, but Wall Street is treating Alexandria as if its dividend is at a material risk of being cut. Only the funds from operations (FFO) payout ratio in the first quarter was a fairly strong 57%. There's room for adversity before a dividend cut would be in order. To be fair, office properties, and particularly highly specialized office properties, tend to have higher operating costs than other real estate assets. But it seems highly likely that Alexandria will manage its way through this weak patch and continue to extend its 15-year streak of annual dividend increases. For income lovers, this healthcare REIT is worth a deep dive in June. The average healthcare stock has an uninspiring dividend yield. But the average is made up of many different companies, some of which actually have very attractive dividend yields. That list includes industry-leading companies like Medtronic and Alexandria Real Estate. You might just want to pick up shares in one, or both, of these high yielders before June is over after you get to know them a little better. Before you buy stock in Medtronic, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Medtronic wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Reuben Gregg Brewer has positions in Medtronic. The Motley Fool has positions in and recommends Alexandria Real Estate Equities. The Motley Fool recommends Medtronic and recommends the following options: long January 2026 $75 calls on Medtronic and short January 2026 $85 calls on Medtronic. The Motley Fool has a disclosure policy. 2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Why Volkswagen is convinced Waymo and Tesla are vulnerable in the $500 billion robotaxi race — ‘not a winner take all market'
Why Volkswagen is convinced Waymo and Tesla are vulnerable in the $500 billion robotaxi race — ‘not a winner take all market'

Yahoo

time11 minutes ago

  • Yahoo

Why Volkswagen is convinced Waymo and Tesla are vulnerable in the $500 billion robotaxi race — ‘not a winner take all market'

The German carmaker is preparing to enter the market for autonomous ride-hailing services next year with its Volkswagen ID. Buzz AD. But instead of competing against existing transportation providers, it aims to work with them as a partner. The different approach comes amid continued popular resentment towards robotaxis. When Big Tech first began deploying self-driving cars to San Francisco two years ago, companies encountered something unusual—popular resistance. Angry residents would sabotage the robotaxis with the help of traffic cones, while the city's fire department chief herself would regularly malign them as a dangerous nuisance. Even today, during the recent outbreak of civil unrest in Los Angeles over mass deportations, protesters caused hundreds of thousands of dollars when they deliberately torched Waymo cars. One old economy company preparing to enter the autonomous ride-hailing space is taking a completely different approach when it launches next year. Germany's Volkswagen is wagering society at large is increasingly fed up with the collateral damage left behind by Silicon Valley's move-fast-and-break-things mentality. 'Our approach is different—we deliberately want to act as partners that build upon existing infrastructure,' VW Group executive Sascha Meyer told Fortune during a test drive of its robotaxi. 'A key point for social acceptance we believe is being a service provider whose presence is desired precisely because we will not be competing with systems already in place.' This week, VW revealed the series production version of its autonomous ride-hailing cab based on its retro-styled VW ID. Buzz EV microbus. Packaged together with the requisite fleet management software and digital customer booking platform, it wants to offer local transportation authorities and other commercial fleets a turnkey solution that can be integrated effortlessly into their service. While a Waymo or a Tesla plan to compete with existing providers, the German carmaker aims to be an equal partner working hand in glove with communities that want their help. Even if the first roughly 500 vehicles won't be deployed to Uber for use in Los Angeles until next year, VW believes the race for market share is only just beginning. It's convinced there will be more than enough demand to grab a bite out of the €350 billion-€450 billion in revenue McKinsey projects for autonomous ride-hailing services in North America and Europe by 2035. That's more than half a trillion dollars worth of growth over the next 10 years, potentially. Meyer runs MOIA, the mobility services subsidiary of the VW Group which will offer a high-tech version of the zero-emission Volkswagen ID. Buzz electric minivan complete with the backend software ecosystem around it. Fortune had a chance to ride along with Meyer in one as the robotaxi navigated its way—with a safety driver behind the wheel at all times—through the busy streets of Hamburg. Here in Germany's second-largest city, Volkswagen has quietly been testing the technology for several years now thanks to the active support of city officials. The white label service Volkswagen has in mind means all customers need to do is slap their logo on the vehicle and adorn the customer-facing front end with their respective corporate identity and they are ready to go. The group's go-to-market strategy heavily incorporates public transit authorities, an approach influenced by its European roots. With their extensive wealth of well-built mass transit networks, these mainly state and municipal-owned companies play a role in urban, suburban and ex-urban mobility so crucial it would be difficult to displace them. Take for example the BVG authority operated by the German capital of Berlin, with whom VW Group already has signeda letter of intent. Three million people entrust their everyday transportation needs to its fine meshed web of buses, streetcars, subways and commuter trains to get back and forth in the greater metropolitan area every day. A BVG-branded robotaxi integrated into its service should see far faster adoption than were Volkswagen to compete alongside it. In a way, VW's partnership approach to the market is a natural fit. Carmakers have decades of experience working closely with regulators from various agencies, state and federal, to ensure their cars conform with traffic safety and environmental standards. In Silicon Valley, however, regulators are often viewed with suspicion—at best an irritant, at worst the enemy. The debacle around robotaxi developer Cruise proved that: following a fateful October 2023 accident in San Francisco, the tech startup deliberately withheld crucial information from crash investigators, shattering what trust was placed in them by the state of California only weeks earlier. When Cruise owner General Motors found out, it acted swiftly to sideline the CEO, but by then it was too late and the reputational damage was done. Cruise ceased all operations and GM pulled out of the autonomous ride-hailing race in December. With crosstown rival Ford already giving up even earlier, only Volkswagen and Hyundai, through its Motional subsidiary, still remain in contention from the legacy car industry. The rest are AI tech companies like Waymo, Tesla, Amazon subsidiary Zoox as well as their foreign equivalents like China's Baidu and Wayve in the UK. Of course, Meyer knows that the competition has a head start they won't hand over willingly. 'Waymo has an indisputable lead, that's clear, and I don't believe they're going to slow down in any way,' he told Fortune. Then there's Tesla, which is gearing up to launch its own pilot in Austin due to launch Sunday. While Meyer readily admits it's likely only a matter of time until Tesla can graduate to a full commercial robotaxi service, he believes all is not lost. For one, neither is present in Europe, a market known for being far more risk-averse towards unproven technologies and quick to regulate against threats towards public safety. Tesla's vaunted Full Self-Driving (FSD) feature, a software stack that will imbue its robotaxis with the requisite intelligence, hasn't yet been approved for use anywhere on the continent. In fact, it's not even available as an advanced driver assist. This offers enough of an opportunity for Volkswagen to greenlight the production of at least 10,000 robotaxi vehicles, potentially more. And even if Waymo and Tesla do retain their lead by the time VW is ready, Meyer believes communities will demand some degree of healthy competition among autonomous ride hailing providers in order to ensure an optimum service for a low cost. 'No one, not even in the United States, will be happy if there's a monopoly,' he said. 'We don't believe it will be a winner-takes-all market.' This story was originally featured on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Tulare County home listings asked for less money in May - see the current median price here
Tulare County home listings asked for less money in May - see the current median price here

Yahoo

time14 minutes ago

  • Yahoo

Tulare County home listings asked for less money in May - see the current median price here

The median home in Tulare County listed for $419,975 in May, slightly down from the previous month's $421,778, an analysis of data from shows. Compared to May 2024, the median home list price slightly decreased from $424,975. The statistics in this article only pertain to houses listed for sale in Tulare County, not houses that were sold. Information on your local housing market, along with other useful community data, is available at Tulare County's median home was 1,774 square feet, listed at $244 per square foot. The price per square foot of homes for sale is up 1.6% from May 2024. Listings in Tulare County moved steadily, at a median 44 days listed compared to the May national median of 51 days on the market. In the previous month, homes had a median of 43 days on the market. Around 352 homes were newly listed on the market in May, a 15% increase from 306 new listings in May 2024. The median home prices issued by may exclude many, or even most, of a market's homes. The price and volume represent only single-family homes, condominiums or townhomes. They include existing homes, but exclude most new construction as well as pending and contingent sales. In California, median home prices were $775,000, a slight increase from April. The median California home listed for sale had 1,775 square feet, with a price of $477 per square foot. Throughout the United States, the median home price was $440,000, a slight increase from the month prior. The median American home for sale was listed at 1,840 square feet, with a price of $234 per square foot. The median home list price used in this report represents the midway point of all the houses or units listed over the given period of time. Experts say the median offers a more accurate view of what's happening in a market than the average list price, which would mean taking the sum of all listing prices then dividing by the number of homes sold. The average can be skewed by one particularly low or high price. The USA TODAY Network is publishing localized versions of this story on its news sites across the country, generated with data from Please leave any feedback or corrections for this story here. This story was written by Ozge Terzioglu. Our News Automation and AI team would like to hear from you. Take this survey and share your thoughts with us. This article originally appeared on Visalia Times-Delta: Tulare County home listings asked for less money in May - see the current median price here

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store